CLINICAL TRIALS PROFILE FOR PROCHLORPERAZINE
✉ Email this page to a colleague
All Clinical Trials for prochlorperazine
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00020657 ↗ | Comparison of Antiemetic Drugs in Preventing Delayed Nausea After Chemotherapy in Patients With Cancer | Completed | National Cancer Institute (NCI) | Phase 3 | 2001-07-01 | RATIONALE: Antiemetic drugs may help to reduce or prevent nausea and vomiting in patients being treated with chemotherapy. PURPOSE: This randomized phase III trial is comparing how well different antiemetic drugs work in preventing delayed nausea after chemotherapy in patients who have cancer. |
| NCT00020657 ↗ | Comparison of Antiemetic Drugs in Preventing Delayed Nausea After Chemotherapy in Patients With Cancer | Completed | Gary Morrow | Phase 3 | 2001-07-01 | RATIONALE: Antiemetic drugs may help to reduce or prevent nausea and vomiting in patients being treated with chemotherapy. PURPOSE: This randomized phase III trial is comparing how well different antiemetic drugs work in preventing delayed nausea after chemotherapy in patients who have cancer. |
| NCT00122278 ↗ | Headache in the Emergency Department (ED) - A Multi-Center Research Network to Optimize the ED Treatment of Migraines | Completed | Montefiore Medical Center | Phase 3 | 2005-07-01 | Migraines are a specific type of headache that frequently recur and are very painful. Although there are many medications that are effective against migraines, none of these medications cure 100% of migraines. Another problem with migraines is that although many times they get better after intravenous (IV) treatment in the emergency room (ER), about 1/3 of the time migraines recur the next day. The purpose of this research project is to see if adding a medication called dexamethasone to standard ER therapy will help patients get better quicker and stay pain-free more often than if they receive placebo. |
| NCT00149578 ↗ | A Phase II Study of Combine Modality Therapy in Locally Advanced Pancreatic Cancer | Unknown status | Chang Gung Memorial Hospital | Phase 2 | 2004-10-01 | Induction chemotherapy will be administered every 2 weeks for 6 cycles (about 3 months). Patients who have radiological evidence of progressive disease will be shifted to salvage chemotherapy. Patients who have responsive or stable disease after induction chemotherapy will receive concurrent chemoradiotherapy 3-4 weeks after the last dose of induction chemotherapy. Surgical evaluation will be performed 4-6 weeks after the completion of chemoradiotherapy. Patients who have resectable disease will undergo surgical resection. Postoperative adjuvant chemotherapy with GOFL for 6 cycles will be given for those who have curative resection. Patients who still have unresectable disease or non-curative resection will receive systemic chemotherapy of GOFL till disease progression or unacceptable toxicity. |
| NCT00149578 ↗ | A Phase II Study of Combine Modality Therapy in Locally Advanced Pancreatic Cancer | Unknown status | China Medical University Hospital | Phase 2 | 2004-10-01 | Induction chemotherapy will be administered every 2 weeks for 6 cycles (about 3 months). Patients who have radiological evidence of progressive disease will be shifted to salvage chemotherapy. Patients who have responsive or stable disease after induction chemotherapy will receive concurrent chemoradiotherapy 3-4 weeks after the last dose of induction chemotherapy. Surgical evaluation will be performed 4-6 weeks after the completion of chemoradiotherapy. Patients who have resectable disease will undergo surgical resection. Postoperative adjuvant chemotherapy with GOFL for 6 cycles will be given for those who have curative resection. Patients who still have unresectable disease or non-curative resection will receive systemic chemotherapy of GOFL till disease progression or unacceptable toxicity. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for prochlorperazine
Condition Name
Clinical Trial Locations for prochlorperazine
Trials by Country
Clinical Trial Progress for prochlorperazine
Clinical Trial Phase
Clinical Trial Sponsors for prochlorperazine
Sponsor Name
